Dr. Charles E Geyer MD
Oncologist | Medical Oncology
1250 E Marshall St Internal Medicine Richmond VA, 23298About
Dr. Charles Geyer is an oncologist practicing in Richmond, VA. Dr. Geyer specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Geyer manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Breast conservation in the treatment of breast cancer: community-based experience.
- Pemetrexed/oxaliplatin for first-line treatment of patients with advanced colorectal cancer: a phase II trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program.
- Trastuzumab for early breast cancer.
- Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences
- Lapatinib plus capecitabine for HER2-positive advanced breast cancer.
- Overcoming treatment challenges in advanced breast cancer.
- Anthracyclines in the treatment of HER2-negative breast cancer.
- A phase III randomized comparison of lapatinib plus capecitabine versus
- Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.
- The emerging role of lapatinib in HER2-positive breast cancer.
- Gemcitabine/epirubicin/paclitaxel as neoadjuvant chemotherapy in locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group.
- HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.
- Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessment.
- Role of trastuzumab in the adjuvant treatment of HER2-positive early breast cancer.
- Efficacy and cardiac safety of adjuvant trastuzumab-based chemotherapy regimens for HER2-positive early breast cancer.
Dr. Charles E Geyer MD's Practice location
Dr. Charles E Geyer MD's reviews
Write ReviewPatient Experience with Dr. Geyer
Recommended Articles
- Do Breast Cancer Patients Receive Too Much Radiation?
When people hear the word “cancer” they naturally become very fearful for their future. Cancer is a terrifying diagnosis to receive and can leave patients feeling uncertain, desperate, confused, yet also motivated to do whatever is in their power to get fight it. This fear can lead to situations...
- What Are the Causes and Symptoms of Bladder Cancer?
Cancer from the lining cells of the bladder may spread to the muscles of the bladder, and from there, will then move to the to lymph nodes and other organs. This cancer may affect people of different ages, but it is more common among older adults. The condition is treatable if detected in the...
- Can Ovarian Cancer Affect Women of All Ages?
Ovarian cancer is the most common type of cancer (besides breast cancer) among the female population. Sometimes, ovarian cancer comes together with many other diseases, such as endometriosis, polycystic ovarian syndrome, irregular periods, and after hormone replacement therapies.This disease is most...
- The Importance of Mentorship in Breast Cancer
Mentorship has been used for centuries for a variety of reasons, from training people in various work trades, to helping university students adjust, and helping people undergoing unique and complex situations cope. With a breast cancer diagnosis, mentoring has been a bright light in the darkness for...
- Can Ovarian Cancer Screening Cause Harm in Women Without Symptoms?
According to a draft of new guidelines relating to screening, ovarian cancer screening in young women who have no symptoms can cause harm and offers no benefits. According to the U.S. Preventative Services Task Force (USPSTF), the screening is not recommended for many women without symptoms. The...
- Can Liver Diseases Lead to Liver Cancer?
What is a liver disease?Liver disease refers to medical complications that cause the liver to be damaged, making it unable to perform its functions properly. The liver is among the most valuable and life-sustaining organs in the body. The reason is that it carries out many important functions that...
Nearby Providers
- Dr. Steven Grant M.D.1250 E Marshall St Richmond VA 23298
- Dr. John Christian Barrett M.D.1250 E Marshall St Richmond VA 23298
- Dr. Edward B. Perkins M.D.1250 E Marshall St Richmond VA 23298
- Dr. Mary Helen Hackney M.D.401 College St Richmond VA 23298
- Dr. Harold M Chung M.D.1250 E Marshall St Richmond VA 23298
- Dr. John M. Mccarty M.D.1101 E Marshall St Richmond VA 23298